ACURA PHARMACEUTICALS, INC. Operating Expenses
ACURA PHARMACEUTICALS, INC. reported Operating Expenses of $2.98 million for the 3-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2015-03-02
- ACURA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2014-12-31 was $2.98M, a 15.13% decline year-over-year.
- ACURA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2014-09-30 was $2.79M, a 15.63% decline year-over-year.
- ACURA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2014-06-30 was $3.31M, a 5.28% increase year-over-year.
- ACURA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2014-03-31 was $3.87M, a 8.95% decline year-over-year.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2014-12-31 | $2.98M 10-K · filed 2015-03-02 | $5.78M derived: sum of 2 quarters · filed 2015-03-02 | $9.08M derived: sum of 3 quarters · filed 2015-03-02 | $12.95M derived: sum of 4 quarters · filed 2015-03-02 |
| 2014-09-30 | $2.79M 10-K · filed 2015-03-02 | $6.10M derived: sum of 2 quarters · filed 2015-03-02 | $9.97M derived: sum of 3 quarters · filed 2015-03-02 | $13.48M derived: sum of 4 quarters · filed 2015-03-02 |
| 2014-06-30 | $3.31M 10-K · filed 2015-03-02 | $7.17M derived: sum of 2 quarters · filed 2015-03-02 | $10.69M derived: sum of 3 quarters · filed 2015-03-02 | $14.00M derived: sum of 4 quarters · filed 2015-03-02 |
| 2014-03-31 | $3.87M 10-K · filed 2015-03-02 | $7.38M derived: sum of 2 quarters · filed 2015-03-02 | $10.69M derived: sum of 3 quarters · filed 2015-03-02 | $13.83M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-12-31 | $3.52M 10-K · filed 2015-03-02 | $6.82M derived: sum of 2 quarters · filed 2015-03-02 | $9.96M derived: sum of 3 quarters · filed 2015-03-02 | $14.21M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-09-30 | $3.31M 10-K · filed 2015-03-02 | $6.45M derived: sum of 2 quarters · filed 2015-03-02 | $10.70M derived: sum of 3 quarters · filed 2015-03-02 | $13.75M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $3.14M 10-K · filed 2014-03-03 | $7.39M derived: sum of 2 quarters · filed 2015-03-02 | $10.45M derived: sum of 3 quarters · filed 2015-03-02 | $12.60M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $4.25M 10-K · filed 2015-03-02 | $7.30M derived: sum of 2 quarters · filed 2015-03-02 | $9.45M derived: sum of 3 quarters · filed 2015-03-02 | $11.64M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $3.06M 10-K · filed 2014-03-03 | $5.21M derived: sum of 2 quarters · filed 2014-03-03 | $7.39M derived: sum of 3 quarters · filed 2014-03-03 | $9.74M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-09-30 | $2.15M 10-K · filed 2014-03-03 | $4.34M derived: sum of 2 quarters · filed 2014-03-03 | $6.68M derived: sum of 3 quarters · filed 2014-03-03 | $8.53M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $2.19M 10-K · filed 2014-03-03 | $4.53M derived: sum of 2 quarters · filed 2014-03-03 | $6.38M derived: sum of 3 quarters · filed 2014-03-03 | $8.53M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $2.34M 10-K · filed 2014-03-03 | $4.19M derived: sum of 2 quarters · filed 2014-03-03 | $6.34M derived: sum of 3 quarters · filed 2014-03-03 | $9.21M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $1.85M 10-K · filed 2013-03-04 | $3.99M derived: sum of 2 quarters · filed 2013-03-04 | $6.87M derived: sum of 3 quarters · filed 2013-03-04 | $9.93M derived: sum of 4 quarters · filed 2013-03-04 |
| 2011-09-30 | $2.15M 10-K · filed 2013-03-04 | $5.02M derived: sum of 2 quarters · filed 2013-03-04 | $8.09M derived: sum of 3 quarters · filed 2013-03-04 | |
| 2011-06-30 | $2.87M 10-K · filed 2013-03-04 | $5.94M derived: sum of 2 quarters · filed 2013-03-04 | ||
| 2011-03-31 | $3.07M 10-K · filed 2013-03-04 |